Do you want to read an article? Please log in or register.
Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial
Type 2 DiabetesPediatric Diabetes
Related content
COMMENTED
Type 2 DiabetesClinical Nutrition
Effect of vitamin D3 supplementation on insulin resistance and β-cell function in prediabetes: a double-blind, randomized, placebo-controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Clin Nutr.
Wallace HJ, Holmes L, Ennis CN, Cardwell CR, Woodside JV, Young IS, Bell PM, Hunter SJ, McKinley MC
doi: 10.1093/ajcn/nqz171.
COMMENTED
Diabetes - GeneralType 2 Diabetes
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
Lancet Diabetes Endocrinol.
Packer M, Claggett B, Lefkowitz MP, McMurray JJV, Rouleau JL, Solomon SD, Zile MR
doi: 10.1016/S2213-8587
Type 2 Diabetes
Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial
Cardiovasc Diabetol
Kusunose K, Imai T, Tanaka A, Dohi K, Shiina K, Yamada T, Kida K, Eguchi K, Teragawa H, Takeishi Y, Ohte N, Yamada H, Sata M, Node K, CANDLE Trial Investigators.
doi: 10.1186/s12933-021-01380-w
Diabetes - GeneralType 2 DiabetesGlycemic Control
Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index
Diabetes Metab Res Rev.
Bonadonna RC, Blonde L, Antsiferov M, Berria R, Gourdy P, Hatunic M, Mohan V, Horowitz M
doi: 10.1002/dmrr.2897.
Diabetes - GeneralGlycemic Control
Dulaglutide Treatment Results in Effective Glycemic Control in Latent Autoimmune Diabetes in Adults (LADA): A Post-Hoc Analysis of the AWARD-2, -4, and -5 Trials
Diabetes Obes Metab.
Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J, Martin S, Schloot NC
doi: 10.1111/dom.13237.
Diabetes - GeneralType 2 Diabetes
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial
Eur Heart J.
Fitchett D, Butler J, van de Borne P, Zinman B, Lachin JM, Wanner C, Woerle HJ, Hantel S, George JT, Erik Johansen O, Inzucchi SE
COMMENTED
Diabetes - GeneralType 1 Diabetes
Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables
Diabetologia.
Wentworth JM, Bediaga NG, Giles LC, Ehlers M, Gitelman SE, Geyer S, Evans-Molina C, Harrison LC; Type 1 Diabetes TrialNet Study Group; Immune Tolerance Network Study Group
doi: 10.1007/s00125-018-4722-z.
Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial
Lancet Gastroenterol Hepatol.
Halawi H, Khemani D, Eckert D, O'Neill J, Kadouh H, Grothe K, Clark MM, Burton DD, Vella A, Acosta A, Zinsmeister AR, Camilleri M
doi: 10.1016/
Diabetes - GeneralType 2 DiabetesGlycemic Control
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
Lancet Diabetes Endocrinol.
Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJ, Solomon SD
doi: 10.1016/S2213-8587